uric acid has been researched along with Cardiac Output, Low in 5 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
Excerpt | Relevance | Reference |
---|---|---|
"We describe a patient with carnitine-acylcarnitine translocase deficiency (MIM 212138), who presented with neonatal generalized seizures, heart failure, and coma." | 3.70 | Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle. ( Dorland, L; Duran, M; IJlst, L; Muntau, AC; Roscher, AA; Röschinger, W; Wanders, RJ, 2000) |
"Allopurinol has been shown to improve endothelial function in chronic heart failure." | 2.72 | High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. ( Belch, JJ; Carr, E; Davies, J; George, J; Struthers, A, 2006) |
"Hyponatremia is one of the most common electrolyte disorders encountered in clinical practice." | 2.46 | Hyponatremia: evaluation and management. ( Carluccio, AL; Merlin, MA; Zenenberg, RD, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zenenberg, RD | 1 |
Carluccio, AL | 1 |
Merlin, MA | 1 |
George, J | 1 |
Carr, E | 1 |
Davies, J | 1 |
Belch, JJ | 1 |
Struthers, A | 1 |
Röschinger, W | 1 |
Muntau, AC | 1 |
Duran, M | 1 |
Dorland, L | 1 |
IJlst, L | 1 |
Wanders, RJ | 1 |
Roscher, AA | 1 |
Shehab, AM | 1 |
Butler, R | 1 |
MacFadyen, RJ | 1 |
Struthers, AD | 1 |
Martínez, A | 1 |
Pérez, P | 1 |
Ossa, C | 1 |
Corbalán, R | 1 |
Jalil, J | 1 |
Castro, P | 1 |
Acevedo, M | 1 |
1 review available for uric acid and Cardiac Output, Low
Article | Year |
---|---|
Hyponatremia: evaluation and management.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Urea Nitrogen; | 2010 |
2 trials available for uric acid and Cardiac Output, Low
Article | Year |
---|---|
High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid.
Topics: Acetylcholine; Aged; Allopurinol; Ascorbic Acid; Blood Pressure; Cardiac Output, Low; Cross-Over Stu | 2006 |
A placebo-controlled study examining the effect of allopurinol on heart rate variability and dysrhythmia counts in chronic heart failure.
Topics: Aged; Allopurinol; Arrhythmias, Cardiac; Cardiac Output, Low; Cross-Over Studies; Data Interpretatio | 2001 |
2 other studies available for uric acid and Cardiac Output, Low
Article | Year |
---|---|
Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle.
Topics: Ammonia; Cardiac Output, Low; Carnitine; Carnitine Acyltransferases; Cells, Cultured; Coma; Consangu | 2000 |
[Hyperuricemia as a marker for anaerobic threshold in chronic cardiac failure].
Topics: Aged; Anaerobic Threshold; Cardiac Output, Low; Chronic Disease; Creatinine; Diuretics; Humans; Male | 2001 |